Coverage / JAZZ / Trade Card

JAZZ

Jazz Pharmaceuticals PLC

OPPORTUNISTIC BUY 2026-08-08 Data 35 days old USD 256.56 Healthcare - BiotechnologyAWAIT ENTRY
ACTIONABLEMethodology gates passed
57

Position levels

Currenttoday
USD 256.56
Buy <=wait / entry
USD 188.33
Trim >=take some off
USD 265.00
Thesis breakA material adverse outcome from SEC review of oxybate revenue recognition (such ...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case24%100 / 10024.0
Base case49%62 / 10030.4
Bear case27%10 / 1002.7
Weighted conviction57 / 100 - OPPORTUNISTIC BUY

Top risks

  • Zepzelca failed to meet primary overall survival goal in late-stage lung cancer study
  • Analyst average price target increased to $255
  • Xywav real-world impact data presented at SLEEP 2026
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.